Literature DB >> 33242202

[Rhabdomyolysis induced by paliperidone palmitate].

Beate Klein1, Christoph Silberbauer2.   

Abstract

Rhabdomyolysis is defined by disintegration of skeletal muscle fibres. Clinical presentation varies and is mostly associated with myalgias as well as elevation of creatine kinase in the serum. Mechanical damage, toxic medicinal factors, and predisposing factors such as myopathies may trigger the condition. This report describes a case of rhabdomyolysis uncovered by chance after administration of paliperidonepalmitate as depot medication in a 45 years old schizophrenic male patient after having tolerated oral risperidone without any problems. Routine screening for clinical manifestations and serum-creatin kinase maybe essential in unravelling antipsychotic-induced rhabdomyolysis.

Entities:  

Keywords:  Antipsychotics; Depot-medication; Early recognition; Paliperidonepalmitate; Rhabdomyolysis

Year:  2020        PMID: 33242202     DOI: 10.1007/s40211-020-00377-3

Source DB:  PubMed          Journal:  Neuropsychiatr        ISSN: 0948-6259


  3 in total

1.  Paliperidone-induced rhabdomyolysis: a case report.

Authors:  Juan G Fernández-Macho; Guadalupe Espárrago-Llorca; Guadalupe R Morales-Gómez; Juan A Guisado-Macías
Journal:  Actas Esp Psiquiatr       Date:  2015-03-01       Impact factor: 1.196

2.  Rhabdomyolysis secondary to quetiapine.

Authors:  Javier Velasco-Montes; Itziar Oriñuela-González; Ainhoa Z Sanjuán-López
Journal:  Actas Esp Psiquiatr       Date:  2012-03-01       Impact factor: 1.196

3.  Rhabdomyolysis with erratic serum creatinin phosphokinase levels: intramuscular injection of haloperidol decanoate.

Authors:  Premnath Reddy Karre; Jeetinder Gujral; Ernesto Rodriguez
Journal:  BMJ Case Rep       Date:  2009-08-17
  3 in total
  1 in total

1.  Acute Dystonia With Rhabdomyolysis Induced by Paliperidone Palmitate: A Rare Adverse Effect.

Authors:  Nishant Allena; Sai Doppalapudi; Sneha Khanal; Steven Tank; Rabih Nasr
Journal:  Cureus       Date:  2022-09-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.